Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
38%(3 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_2
2
18%
Ph not_applicable
1
9%
Ph phase_4
1
9%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(2)
Other(1)

Detailed Status

Completed8
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

terminated218%
completed873%
unknown19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_4

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

NCT02675647
unknown

Optimization Strategy for Oxygen Delivery Under Cardiopulmonary Bypass

NCT05984563
terminatedphase_2

Vitamin B12a Vasoplegic Syndrome

NCT03735316
terminated

Bypass vs. Ecmo in Lung Transplantation (BELT)

NCT03021538
completed

Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)

NCT02405195
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02675647Phase 4

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

Completed
NCT05984563

Optimization Strategy for Oxygen Delivery Under Cardiopulmonary Bypass

Unknown
NCT03735316Phase 2

Vitamin B12a Vasoplegic Syndrome

Terminated
NCT03021538

Bypass vs. Ecmo in Lung Transplantation (BELT)

Terminated
NCT02405195

Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)

Completed
NCT03023670Not Applicable

Lung Protection and Pediatric Cardiac Surgery

Completed
NCT02548975

Risk Factors for Delirium Following Cardiac Surgery

Completed
NCT00000470Phase 3

Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest

Completed
NCT02410642

NAG-excretion During Cardiopulmonary Bypass

Completed
NCT00000604Phase 2

Influence of CPB Temperature on CABG Morbidity

Completed
NCT00745810

Anesthetic Management and Remote Reperfusion Injuries

Completed

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11